Barclays raised its target from $96 to $101, but kept an 'Underweight' rating and said it still implies about 20.2% downside. The continued warning outweighs the higher target.
The higher target softens the warning, but Barclays kept a negative rating and still sees room for the shares to fall. That continued warning matters more than the target increase.
Follow Addus HomeCare Corporation (ADUS) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for ADUS